Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edwards Lifesciences (EW)
NYSE:EW
Holding EW?
Track your performance easily
Earnings Data
Report Date
Jan 30, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.55Last Year’s EPS
$0.64Same Quarter Last Year
Moderate Buy
Based on 23 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 24, 2024
|% Change Since: 6.34%
|Next Earnings Date:Jan 30, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance with significant growth in key segments like TMTT and surgical operations. However, challenges such as capacity constraints and market pressures in specific regions temper the outlook. Overall, the positive aspects slightly outweigh the negatives, indicating steady strategic progress and strong financial performance.Company Guidance
In the third quarter of 2024, Edwards Lifesciences reported financial results with a sales increase of 10% on a constant currency basis, reaching $1.4 billion, driven by strong performances in TAVR and TMTT. The company's adjusted gross profit margin was 80.7%, and the adjusted operating profit margin was 31.4%. Edwards maintained its full-year sales growth guidance of 8% to 10%, with specific expectations for TAVR growth of 5% to 7%. The company anticipates fourth-quarter sales to be between $1.33 billion and $1.39 billion, with EPS guidance set at $0.53 to $0.57. For 2025, Edwards expects operating margins to be in the range of 27% to 28%, reflecting the impact of recent acquisitions and rightsizing efforts. The company also emphasized its commitment to long-term growth through innovative structural heart therapies, including the launch of new products like PASCAL and EVOQUE, as well as strategic expansions into new therapeutic areas such as aortic regurgitation and implantable heart failure management.Strong Financial Performance
Edwards Lifesciences reported Q3 2024 sales from continuing operations of $1.35 billion with underlying sales growth of 9.6% and adjusted EPS of $0.67, slightly ahead of expectations.
Growth in TMTT Segment
The TMTT segment achieved $91 million in sales, representing 74% growth over the prior year, led by the PASCAL repair system.
Advancements in Clinical Research
Important advancements were made in clinical research and new product introductions, including trials like EARLY TAVR and TRISCEND II, showcasing Edwards' commitment to innovation.
Surgical Segment Growth
Surgical sales from continuing operations increased by 5% over the prior year, driven by strong adoption of premium surgical technologies.
Successful Disposition of Critical Care
Edwards successfully closed the sale of its Critical Care segment, aligning with its focus on structural heart innovations.
---
EW Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
EW Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 24, 2024 | $70.35 | $69.38 | -1.38% |
| Jul 24, 2024 | $86.95 | $59.70 | -31.34% |
| Apr 25, 2024 | $88.01 | $86.43 | -1.80% |
| Feb 06, 2024 | $88.25 | $86.61 | -1.86% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Edwards Lifesciences (EW) report earnings?
Edwards Lifesciences (EW) is schdueled to report earning on Jan 30, 2025, TBA Not Confirmed.
What is Edwards Lifesciences (EW) earnings time?
Edwards Lifesciences (EW) earnings time is at Jan 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EW EPS forecast?
EW EPS forecast for the fiscal quarter 2024 (Q4) is $0.55.
---